AzPA Pharmacy Flash
Nov. 5, 2014

Dengue fever has reached the Mexico-Arizona border
Dengue fever has reached the Mexico-Arizona border. The Arizona Department of Health Services is monitoring five cases along Yuma County. Center for Disease Control: "The virus is a leading cause of illness and death in the tropics and subtropics. As many as 400 million people are infected yearly." For more information about dengue fever, visit the CDC website. More

Ebola: Resources for healthcare workers
AzPA has a resource page to keep you informed on Ebola safety protocols. View fact sheets and toolkits from the Center for Disease Control, Arizona Department of Health Services, World Health Organization, American Hospital Association and the American Society of Health-Systems Pharmacists. Click here for more information. More

LAST WEEK TO REGISTER: Psychiatric & Diabetes Care Certificate Programs
It all happens Friday, Nov. 14, in Phoenix. Learn how to effectively manage the pharmacotherapy of patients with psychiatric disorders with AzPA's Psychiatric Certificate Program. Or become an expert diabetes educator through the Diabetes Care Certificate. Hurry! Online registration ends this Friday, Nov. 7! More

Join AzPA in Phoenix the second week of November for pharmacy education. Attend a day of CE sessions to enhance your clinical skills in Medication Management, Parkinson's disease and more. Technicians: We have technician-specific CEs for you, as required by the 2015 PTCB mandates. Online registration closes Nov. 7! More

Attention technicians: 2015 certification updates
Beginning in 2015, the Pharmacy Technician Certification Board will only accept technician-specific CEs in order to be eligible for recertification. CE programs intended for pharmacists and pharmacy technicians will have an identical Universal Activity Number with a target audience designator of either "P" or "T" as the last digit. In 2015 and beyond, PTCB does not accept CE that is not pharmacy-technician specific. If you have already earned CE that is pharmacist-specific (P-specific), PTCB recommends checking with your CE provider to see if the provider offers an equivalent course listed with a T-specific designation. For questions of concerns view the PTCB Changes in Recertification Requirements Fact Sheet. More

AzPA Immunization Certificate Program Nov. 20: Seats are limited!
Due to popular demand, AzPA just scheduled an Immunization Certificate Program for Thursday, Nov. 20, at the Association Office in Tempe. This educational program provides pharmacists and student pharmacists with the skills necessary to become primary sources for vaccine advocacy, education and administration. The program reviews the basics of immunology, identifies legal and regulatory issues pharmacists must consider before starting an immunization program, and focuses on practice implementation. But hurry, seats are limited! Register today! More

Should we feel sorry for Big Pharma's struggles?
By Mike Wokasch
Are we feeling sorry for the struggling pharmaceutical industry yet? Generic drugs continue to replace many of the multibillion-dollar blockbuster products of the past. Biosimilars threaten extraordinary revenues and profits of the once-seemingly-irreplaceable specialty biologics. Research pipelines are depleted, and the cost of discovering and developing new products is reported to be more than a billion dollars. At the same time, the cost of acquiring technologies from universities and small biotech companies has skyrocketed.More

Pharmacist supply and demand: Past, present and future
Pharmacy Times
Katie Zavadski starts her article, "The Pharmacy School Bubble Is About to Burst," by describing the good ol' days of pharmacy. It was just a few years ago that jobs for recent pharmacy graduates offered six figures, a competitive signing bonus and a choice of several work locations. Recruitment events brought many job opportunities that were spread between just a few graduates; the demand was clearly greater than the supply. More

CVS's sneaky move to recoup loss of tobacco sales
By Jason Poquette
When drugstore giant CVS Health decided to discontinue the sale of cigarettes in their CVS pharmacies, many folks in the healthcare community applauded their noble move. In spite of the loss of millions of dollars in sales, they pulled the plug on this line of income in an effort simply to position themselves as a "healthier" place to shop. Or so we thought. As it turns out, there appears to have been an ulterior motive that would effectively recoup the sales losses on the cancer-causing tobacco products. More

Apple's HealthKit may improve health data reporting
Pharmacy Times
Will using HealthKit during the day keep adverse events away? Apple Inc. certainly hopes so, as it has entered into research studies with two major hospitals to determine how its new tool will work in practice, Reuters reported in September. Although HealthKit is still under development, the service aggregates data from various mobile health apps, once the patient consents to it. From there, healthcare providers can view the collected data, which can be gathered from tracking apps or compatible peripheral devices. More

American Pharmacists Month 2014: Celebrations from coast to coast
Pharmacists, student pharmacists, pharmacy technicians and APhA staff participated in events across the country to promote the valuable role pharmacists play in healthcare during American Pharmacists Month. Throughout October, participants enjoyed activities and events that featured the theme "Know Your Pharmacist — Know Your Medicine." More

Study: Typical ADHD care leaves room for improvement
HealthDay News
Many pediatricians provide inadequate care for children with attention deficit hyperactivity disorder, relying too heavily on drugs and failing to thoroughly assess kids' symptoms, a new study reports. Nearly one-third of pediatricians who diagnose children with ADHD do not consult the Diagnostic and Statistical Manual of Mental Disorders, a necessary step in determining if the kids meet the criteria for the brain disorder, researchers found. More

FDA approves 1st vaccine to prevent serogroup B meningococcal disease
Pharmacy Practice News
The FDA approved a new vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals aged 10 to 25 years. Trumenba, the first N. meningitidis serogroup B vaccine licensed in the United States, was reviewed and approved under the FDA's breakthrough therapy designation and priority review programs. More